Effect of Simvastatin Treatment on “In Vitro” NLRP1 Inflammasome Expression in Peripheral Arterial Disease

Simvastatin intake in PAD patients increases in vitro reactivity of NLRP1 inflammasome gene expression in HAECs, especially in critical limb ischemia patients.